Magnetic resonance imaging of the brain may help physicians predict patient outcomes following a cardiac arrest.
Determining MR imaging-based measures of the brain within two weeks of a patient’s cardiac arrest may help physicians predict patient clinical outcomes, according to a study published in Radiology.
Researchers from the United States and France performed a prospective multicenter study to assess whether early brain functional connectivity is associated with functional recovery one year after cardiac arrest.
Forty-six patients who were comatose after a cardiac arrest were enrolled in the study. The principle outcome was cerebral performance category at 12 months. A favorable outcome was defined as cerebral performance category 1 or 2.
All participants underwent multiparametric structural and functional MR imaging less than 4 weeks (mean of 12.6 days) after their cardiac arrest. Using seed-based analysis of resting-state functional MR imaging data, within- and between-network connectivity was measured in:
• Dorsal attention network (DAN)
• Default-mode network (DMN)
• Salience network (SN)
• Executive control network (ECN)
Structural changes identified with fluid-attenuated inversion recovery and diffusion-weighted imaging sequences were analyzed by using validated morphologic scales. The association between connectivity measures, structural changes, and the principal outcome was explored with multivariable modeling.
The results showed at 12 months, 11 patients had a favorable outcome. Patients with favorable outcome had higher within-DMN connectivity and greater anticorrelation between SN and DMN and between SN and ECN compared with patients with unfavorable outcome, an effect that was maintained after multivariable adjustment. Anticorrelation of SN-DMN predicted outcomes with higher accuracy than fluid-attenuated inversion recovery or diffusion-weighted imaging scores.
The researchers concluded that using MR imaging to measure cerebral functional network connectivity obtained in the acute phase of CA were independently associated with favorable outcome at one year. The authors suggested that these findings warranted validation as early markers of long-term recovery potential in patients with anoxic-ischemic encephalopathy.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.
MRI Research Suggests Link Between COVID-19 Related Brain Fog and Blood-Brain Barrier Dysfunction
February 23rd 2024For people with COVID-19 related brain fog, emerging dynamic contrast-enhanced MRI (DCE-MRI) research findings revealed blood-brain barrier disruption in multiple brain regions, including temporal lobes and the frontal cortex, up to a year after active infection.